Dr. Daniel George on the Treatment Landscape for RCC

June 11, 2019
Daniel George, MD

Cancer Network spoke with Daniel George, MD, of Duke Health, about the treatment landscape and current trials for renal cell carcinoma.

Cancer Network spoke with Daniel George, MD, of Duke Health, about the treatment landscape and current trials for renal cell carcinoma.

Related Content:

American Society of Clinical Oncology Annual Meeting (ASCO)Renal Cell Carcinoma
Pembrolizumab Plus Lenvatinib Earns Priority Review in 2 Disease Indications
New Potential Frontline Standards for RCC Are Spotlighted at Genitourinary Cancers Symposium
Safety and Efficacy of Investigational Agents Under Evaluation in Umbrella Study for Advanced RCC